» Articles » PMID: 26452220

Nav1.5 Regulates Breast Tumor Growth and Metastatic Dissemination in Vivo

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Oct 10
PMID 26452220
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Voltage-gated Na+ channels (VGSCs) mediate action potential firing and regulate adhesion and migration in excitable cells. VGSCs are also expressed in cancer cells. In metastatic breast cancer (BCa) cells, the Nav1.5 α subunit potentiates migration and invasion. In addition, the VGSC-inhibiting antiepileptic drug phenytoin inhibits tumor growth and metastasis. However, the functional activity of Nav1.5 and its specific contribution to tumor progression in vivo has not been delineated. Here, we found that Nav1.5 is up-regulated at the protein level in BCa compared with matched normal breast tissue. Na+ current, reversibly blocked by tetrodotoxin, was retained in cancer cells in tumor tissue slices, thus directly confirming functional VGSC activity in vivo. Stable down-regulation of Nav1.5 expression significantly reduced tumor growth, local invasion into surrounding tissue, and metastasis to liver, lungs and spleen in an orthotopic BCa model. Nav1.5 down-regulation had no effect on cell proliferation or angiogenesis within the in tumors, but increased apoptosis. In vitro, Nav1.5 down-regulation altered cell morphology and reduced CD44 expression, suggesting that VGSC activity may regulate cellular invasion via the CD44-src-cortactin signaling axis. We conclude that Nav1.5 is functionally active in cancer cells in breast tumors, enhancing growth and metastatic dissemination. These findings support the notion that compounds targeting Nav1.5 may be useful for reducing metastasis.

Citing Articles

Neuronal mimicry in tumors: lessons from neuroscience to tackle cancer.

Bloomer H, Dame H, Parker S, Oudin M Cancer Metastasis Rev. 2025; 44(1):31.

PMID: 39934425 PMC: 11813822. DOI: 10.1007/s10555-025-10249-3.


Clinical relevance of macromolecular complexes involving integrins, potassium and sodium ion channels and the sodium/proton antiporter in human breast cancer.

Lastraioli E, Iorio J, Piazza F, Capitani C, Santillo M, Duranti C Cancer Cell Int. 2025; 25(1):24.

PMID: 39865220 PMC: 11765915. DOI: 10.1186/s12935-025-03653-w.


Effects of Na1.5 and Rac1 on the Epithelial-Mesenchymal Transition in Breast Cancer.

Zha Z, Ge F, Li N, Zhang S, Wang C, Gong F Cell Biochem Biophys. 2024; .

PMID: 39673684 DOI: 10.1007/s12013-024-01625-x.


Role of SIK1 in tumors: Emerging players and therapeutic potentials (Review).

Zhang X, Liu J, Zuo C, Peng X, Xie J, Shu Y Oncol Rep. 2024; 52(6).

PMID: 39422046 PMC: 11544583. DOI: 10.3892/or.2024.8828.


Voltage-gated sodium channels in cancers.

Liu H, Weng J, Huang C, Jackson A Biomark Res. 2024; 12(1):70.

PMID: 39060933 PMC: 11282680. DOI: 10.1186/s40364-024-00620-x.


References
1.
Harvey J, Clark G, Osborne C, Allred D . Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999; 17(5):1474-81. DOI: 10.1200/JCO.1999.17.5.1474. View

2.
Eccles S, Aboagye E, Ali S, Anderson A, Armes J, Berditchevski F . Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res. 2013; 15(5):R92. PMC: 3907091. DOI: 10.1186/bcr3493. View

3.
George Jr A . Inherited disorders of voltage-gated sodium channels. J Clin Invest. 2005; 115(8):1990-9. PMC: 1180550. DOI: 10.1172/JCI25505. View

4.
Fraser S, Diss J, Chioni A, Mycielska M, Pan H, Yamaci R . Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res. 2005; 11(15):5381-9. DOI: 10.1158/1078-0432.CCR-05-0327. View

5.
Yang M, Kozminski D, Wold L, Modak R, Calhoun J, Isom L . Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer. Breast Cancer Res Treat. 2012; 134(2):603-15. PMC: 3401508. DOI: 10.1007/s10549-012-2102-9. View